{"id":2054,"date":"2026-03-11T13:18:27","date_gmt":"2026-03-11T10:18:27","guid":{"rendered":"https:\/\/gundexia.com\/?p=2054"},"modified":"2026-03-11T13:18:30","modified_gmt":"2026-03-11T10:18:30","slug":"mrna-onculeri-yeni-yol-ciziyor-biontech-kuruculari-gorev-birakacak","status":"publish","type":"post","link":"https:\/\/gundexia.com\/?p=2054","title":{"rendered":"MRNA \u00f6nc\u00fcleri yeni yol \u00e7iziyor: BioNTech kurucular\u0131 g\u00f6rev b\u0131rakacak"},"content":{"rendered":"\n<p>Almanya merkezli biyoteknoloji \u015firketi <strong>BioNTech<\/strong>\u2019in kurucular\u0131 <strong>U\u011fur \u015eahin<\/strong> ve <strong>\u00d6zlem T\u00fcreci<\/strong>, \u015firket y\u00f6netimindeki g\u00f6revlerinden ayr\u0131lma karar\u0131 ald\u0131. COVID-19 d\u00f6neminde geli\u015ftirdikleri mRNA a\u015f\u0131s\u0131yla d\u00fcnya \u00e7ap\u0131nda tan\u0131nan ikilinin, yeni bir biyoteknoloji giri\u015fimi kurmaya haz\u0131rland\u0131\u011f\u0131 a\u00e7\u0131kland\u0131.<\/p>\n\n\n\n<p>\u015eirketten yap\u0131lan a\u00e7\u0131klamaya g\u00f6re \u015eahin ve T\u00fcreci\u2019nin mevcut s\u00f6zle\u015fmeleri <strong>2026 y\u0131l\u0131 sonunda<\/strong> sona erecek ve bu tarihe kadar g\u00f6revlerini s\u00fcrd\u00fcrmeleri bekleniyor. Ard\u0131ndan kurucular, mRNA teknolojisinin yeni nesil uygulamalar\u0131na odaklanan ba\u011f\u0131ms\u0131z bir \u015firketin y\u00f6netimine ge\u00e7ecek.<\/p>\n\n\n\n<p>Yeni giri\u015fimin \u00f6zellikle <strong>mRNA tabanl\u0131 ila\u00e7lar ve kanser tedavileri<\/strong> \u00fczerine yo\u011funla\u015faca\u011f\u0131 belirtiliyor. BioNTech\u2019in de baz\u0131 mRNA teknolojilerini ve ilgili haklar\u0131 yeni \u015firkete devretmeyi de\u011ferlendirdi\u011fi ifade edildi.<\/p>\n\n\n\n<p>Pandemi s\u0131ras\u0131nda Pfizer ile birlikte geli\u015ftirilen COVID-19 a\u015f\u0131s\u0131 sayesinde k\u00fcresel \u00e7apta b\u00fcy\u00fcyen BioNTech, son y\u0131llarda yeniden <strong>kanser tedavileri ve yeni nesil mRNA ila\u00e7lar\u0131<\/strong> \u00fczerinde \u00e7al\u0131\u015fmalar\u0131n\u0131 yo\u011funla\u015ft\u0131rm\u0131\u015f durumda. Kurucular\u0131n ayr\u0131lmas\u0131n\u0131n ard\u0131ndan \u015firket y\u00f6netimi i\u00e7in yeni isimlerin belirlenmesi s\u00fcreci ba\u015flat\u0131ld\u0131.<\/p>\n\n\n\n<p>Kaynak: <a href=\"https:\/\/www.hurriyet.com.tr\/dunya\/biontechten-ayriliyorlar-43126008\">BioNTech\u2019ten ayr\u0131l\u0131yorlar &#8211; H\u00fcrriyet En Son Haberler<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Almanya merkezli biyoteknoloji \u015firketi BioNTech\u2019in kurucular\u0131 U\u011fur \u015eahin ve \u00d6zlem T\u00fcreci, \u015firket y\u00f6netimindeki g\u00f6revlerinden ayr\u0131lma karar\u0131 ald\u0131. COVID-19 d\u00f6neminde geli\u015ftirdikleri mRNA a\u015f\u0131s\u0131yla d\u00fcnya \u00e7ap\u0131nda tan\u0131nan ikilinin, yeni bir biyoteknoloji giri\u015fimi kurmaya haz\u0131rland\u0131\u011f\u0131 a\u00e7\u0131kland\u0131. \u015eirketten yap\u0131lan a\u00e7\u0131klamaya g\u00f6re \u015eahin ve T\u00fcreci\u2019nin mevcut s\u00f6zle\u015fmeleri 2026 y\u0131l\u0131 sonunda sona erecek ve bu tarihe kadar g\u00f6revlerini s\u00fcrd\u00fcrmeleri bekleniyor. Ard\u0131ndan [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2055,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-2054","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dunya"],"jetpack_featured_media_url":"https:\/\/gundexia.com\/wp-content\/uploads\/2026\/03\/69b0a2647a5d6587c58244c1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/posts\/2054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gundexia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2054"}],"version-history":[{"count":1,"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/posts\/2054\/revisions"}],"predecessor-version":[{"id":2056,"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/posts\/2054\/revisions\/2056"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/media\/2055"}],"wp:attachment":[{"href":"https:\/\/gundexia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gundexia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gundexia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}